A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recenvonset rheumatoid arthritis.

被引：0
|
作者：
Wessels, Judith A. M.
van der Kooij, Sjoerd M.
Le Cessie, Saskia
Allaart, Cornelia F.
de Vries-Bouwstra, Jeska
Goekoop-Ruiterman, Yvonne P. M.
de Jonge, Robert
van der Straaten, Tahar
Huizinga, Tom W. J.
Guchelaar, Henk-Jan
机构：
[1] Fdn Appl Rheumatol Res, Leiden, Netherlands
[2] LUMC, Leiden, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4048 / 4049
页数：2
相关论文
共 50 条
  • [1] A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis
    Wessels, Judith A. M.
    van der Kooij, Sjoerd M.
    le Cessie, Saskia
    Kievit, Wietske
    Barerra, Pilar
    Allaart, Cornelia F.
    Huizinga, Tom W. J.
    Guchelaar, Henk-Jan
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1765 - 1775
  • [2] Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort
    Owen, S. A.
    Lunt, M.
    Hider, S. L.
    Bruce, I. N.
    Barton, A.
    Thomson, W.
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (12): : 3827 - 3829
  • [3] Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients
    Eektimmerman, Frank
    Allaart, Cornelia F.
    Hazes, Johanna M. W.
    den Broeder, Alfons A.
    Fransen, Jaap
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    [J]. PHARMACOGENOMICS, 2019, 20 (02) : 85 - 93
  • [4] Clinical efficacy of combination therapy of prospidin and methotrexate vs monotherapy of methotrexate for rheumatoid arthritis
    Nemtsov, BF
    Simonova, OV
    Politova, NN
    Benenson, EV
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 168 - 168
  • [5] Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure
    Fransen, Jaap
    Kooloos, Wouter M.
    Huizinga, Tom W. J.
    Guchelaar, Henk-Jan
    van Riel, Piet L. C. M.
    Barrera, Pilar
    [J]. PHARMACOGENOMICS, 2012, 13 (09) : 1087 - 1094
  • [6] Radiographic, Clinical and Functional Comparison of Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis.
    Lee, Eun Bong
    Fleischmann, Roy M.
    Hall, Stephen
    van Vollenhoven, Ronald F.
    Bradley, John
    Gruben, David
    Koncz, Tamas
    Krishnaswami, Sriram
    Wallenstein, Gene
    Zwillich, Samuel H.
    Wilkinson, Bethanie E.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1049 - S1049
  • [7] Dietary caffeine intake and methotrexate efficacy in rheumatoid arthritis.
    Benito-Garcia, E
    Maher, NE
    Matthews, HM
    Bilics, JA
    Karlson, J
    Weinblatt, ME
    Shadick, NA
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S552 - S552
  • [8] The effect of methotrexate monotherapy on impaired B cell tolerance in rheumatoid arthritis.
    Samuels, J
    Meffre, E
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4082 - 4082
  • [9] Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study
    Meltem Alkan Melikoglu
    Eda Balkan
    [J]. Inflammopharmacology, 2022, 30 : 193 - 197
  • [10] Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study
    Melikoglu, Meltem Alkan
    Balkan, Eda
    [J]. INFLAMMOPHARMACOLOGY, 2022, 30 (01) : 193 - 197
12345